| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |